Computational Evaluation of Antibacterial Activity of Acalypha indica L. Phytochemicals Against Staphylococcus aureus DNA Gyrase

Lisa Savitri, Kharisul Ihsan, Elfred Rinaldo Kasimo, Rochmad Krissanjaya

Abstract


This study investigated the antibacterial potential of phytochemical compounds derived from Acalypha indica L. against the DNA gyrase of Staphylococcus aureus using an in silico computational approach. Phytochemical structures were collected from established compound databases and subjected to geometry optimization to ensure conformational stability before molecular docking analysis. Docking simulations were carried out using AutoDock Vina to evaluate the binding affinity and interaction profiles of each ligand with the ATP-binding domain of DNA gyrase, a critical enzyme involved in bacterial DNA replication. The three-dimensional structure of S. aureus DNA gyrase was obtained from the Protein Data Bank and prepared through removal of water molecules, addition of polar hydrogens, and refinement of active-site residues. Among the screened ligands, five compounds exhibited strong predicted affinities, with binding energies ranging from -6.8 to -9.1 kcal/mol. Compound C demonstrated the most favorable interaction, forming stable hydrogen bonds and extensive hydrophobic contacts within the catalytic pocket, suggesting a strong inhibitory potential. Compound E also showed a high affinity, although its orientation within the binding site was slightly less optimal. ADMET predictions indicated that all top candidates satisfied drug-likeness criteria, showed good absorption potential, and presented low toxicity risks. Overall, the findings highlight that Acalypha indica L. contains bioactive constituents with promising inhibitory activity against bacterial DNA gyrase. These results support the traditional use of the plant in antimicrobial applications and provide a foundation for further experimental validation through in vitro enzyme inhibition assays and in vivo studies to confirm their therapeutic relevance.

Keywords


Acalypha indica L.; antibacterial activity; DNA gyrase; Staphylococcus aureus; molecular docking

Full Text:

PDF

References


Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014). Mechanisms of quinolone action and resistance. Biochemistry, 53(10), 1565–1574.

Banerjee, P., Eckert, A. O., Schrey, A. K., & Preissner, R. (2018). ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Research, 46(W1), W257–W263.

Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., … Bourne, P. E. (2000). The Protein Data Bank. Nucleic Acids Research, 28(1), 235–242.

Biovia. (2020). Discovery Studio Visualizer. Dassault Systèmes.

Blower, T. R., Williamson, B. H., Kerns, R. J., & Berger, J. M. (2016). Crystal structure and stability of gyrase–DNA complexes. Nature Communications, 7, 10186.

Bush, N. G., Diez-Santos, I., Abbott, L. R., & Maxwell, A. (2017). Quinolones: Mechanism, lethality and their contributions to antibiotic resistance. Molecular Microbiology, 107(2), 204–224.

Chambers, H. F., & DeLeo, F. R. (2015). Waves of resistance: Staphylococcus aureus in the antibiotic era. Nature Reviews Microbiology, 7, 629–641.

Cushnie, T. P. T., & Lamb, A. J. (2014). Recent advances in understanding the antibacterial properties of flavonoids. International Journal of Antimicrobial Agents, 44(5), 377–386.

Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717.

DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016). Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics, 47, 20–33.

Drlica, K., Malik, M., Kerns, R. J., & Zhao, X. (2009). Quinolone-mediated bacterial death. Antimicrobial Agents and Chemotherapy, 53(11), 4240–4246.

Ekins, S., Mestres, J., & Testa, B. (2007). In silico pharmacology for drug discovery. Journal of Pharmacological and Toxicological Methods, 55(2), 133–151.

Ferreira, L. G., Santos, R. N. d., Oliva, G., & Andricopulo, A. D. (2015). Molecular docking and structure-based drug design strategies. Molecules, 20(7), 13384–13421.

Halgren, T. A. (1996). Merck molecular force field. Journal of Computational Chemistry, 17(5–6), 490–519.

Harborne, J. B. (1998). Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis. Springer.

Hooper, D. C., & Jacoby, G. A. (2019). Mechanisms of drug resistance: Quinolone resistance. Annals of the New York Academy of Sciences, 1354(1), 12–31.

Huang, J., Rauscher, S., Nawrocki, G., Ran, T., Feig, M., Groot, B. L., … MacKerell, A. D. (2017). CHARMM36m: An improved force field for folded and intrinsically disordered proteins. Nature Methods, 14, 71–73.

Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., … Bolton, E. E. (2021). PubChem in 2021: New data content and improved web interfaces. Nucleic Acids Research, 49(D1), D1388–D1395.

Kumar, R. S., Rajkapoor, B., & Perumal, P. (2016). Phytochemical and pharmacological profile of Acalypha indica L. Journal of Ethnopharmacology, 180, 262–276.

Levine, C., Hiasa, H., & Marians, K. J. (2012). DNA gyrase and topoisomerase IV: Biochemical activities, physiological roles, and drug targets. Annual Review of Biochemistry, 81, 70–95.

Li, X., Xu, Y., & Wang, X. (2021). In vivo toxicity and pharmacokinetics of plant-derived antibacterial agents. Phytomedicine, 92, 153753.

Lipinski, C. A. (2004). Lead- and drug-like compounds: The rule-of-five revolution. Drug Discovery Today: Technologies, 1(4), 337–341.

Liu, X., Ouyang, S., & Yu, B. (2020). Computational methods in drug discovery. Pharmacology & Therapeutics, 212, 107577.

Morris, G. M., Huey, R., & Olson, A. J. (2009). Using AutoDock for ligand–receptor docking. Current Protocols in Bioinformatics, 24, 8.14.1–8.14.40.

Mukherjee, P. K. (2019). Plant-based ADMET profiling in drug discovery. Phytotherapy Research, 33(4), 771–785.

Newman, D. J., & Cragg, G. M. (2020). Natural products as sources of new drugs over the last 40 years. Journal of Natural Products, 83(3), 770–803.

Ntie-Kang, F. (2014). Modeling natural product datasets for virtual screening. Future Science OA, 1(1).

Otto, M. (2018). Staphylococcus aureus toxins. Nature Reviews Microbiology, 16, 182–194.

Pandey, R., Chandan, R. S., & Verma, R. (2019). Phytochemical–protein docking studies in antibacterial drug discovery. Computational Biology and Chemistry, 78, 49–59.

Pronk, S., Pall, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R., … Hess, B. (2013). GROMACS 4.5: A high-throughput and highly parallel open-source molecular simulation toolkit. Bioinformatics, 29(7), 845–854.

Singh, A., Kumar, S., & Pandey, A. K. (2018). Phytochemical and pharmacological properties of medicinal plants. Frontiers in Pharmacology, 9, 140.

Tomar, R., Singh, R., & Gupta, R. (2020). Validation of docking results with in vitro antibacterial assays. Journal of Molecular Modeling, 26, 320.

Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking. Journal of Computational Chemistry, 31(2), 455–461.




DOI: https://doi.org/10.14421/biomedich.2026.151.451-455

Refbacks

  • There are currently no refbacks.




Copyright (c) 2026 Lisa Savitri, Kharisul Ihsan, Elfred Rinaldo Kasimo, Rochmad Krissanjaya



Biology, Medicine, & Natural Product Chemistry
ISSN 2089-6514 (paper) - ISSN 2540-9328 (online)
Published by Sunan Kalijaga State Islamic University & Society for Indonesian Biodiversity.

CC BY NC
This work is licensed under a CC BY-NC